Literature DB >> 33867727

Clinico-Hematological Profile of Paroxysmal Nocturnal Hemoglobinuria in Indian Patients: FLAER Flow Cytometry Based Experience from an Indian Tertiary Care Centre.

Priyanka Mishra1, Preeti Tripathi2, Rohan Halder1, Renu Saxena1, Seema Tyagi1, Manoranjan Mahapatra1, H P Pati1.   

Abstract

PNH is a rare disease with wide spectrum of intra-vascular hemolysis and thrombosis to sub-clinical PNH clones. We aimed to study the clinico-hematological profile and clone size on granulocytes and monocytes of PNH patients classified as per International PNH Interest Group recommendations. A retrospective analysis of clinico-hematological profile of 112 PNH clone positive patients by FLAER based flow cytometry between January and September 2017 done and classified into classical PNH, PNH with aplastic anemia or myelodysplastic syndrome (PNH-AA/MDS) and sub-clinical PNH clones (PNH-sc). Of 112 patients, majority were PNH-sc (62) followed by PNH-AA/MDS (34) and classical PNH (16). The commonest clinical feature was anemia in all 3 groups followed by jaundice (87.5%) in classical PNH and fever in PNH-AA/MDS (64.7%) and PNH-sc (48.4%). Thrombosis was present in 25% (4/16) classical PNH and 2.9% (1/34) of PNH-AA/MDS. The mean hemoglobin, reticulocyte count and LDH was higher in classical PNH. Bone marrow was predominantly hypercellular in classical PNH (11/16) and hypocellular in PNH-AA/MDS (31/34) and PNH-sc (50/62) with dyserythropoiesis predominantly in PNH-AA/MDS (83.8%) and PNH-sc (74.1%). Marrow iron was reduced in 62.2% classical PNH contrary to increased in PNH-BMF (58%) and PNH-sc (91%). The mean clone size in PNH-sc was significantly lower with > 50% in 16.2% patients. Three patients with MDS-MLD and MDS-MLD-RS in PNH-sc had > 80% clone on granulocytes and monocytes. Most PNH patients in Indian setting are PNH-sc with significantly lower clone, however, a clone size > 50% is not uncommon in Indian PNH-sc. © Indian Society of Hematology and Blood Transfusion 2020.

Entities:  

Keywords:  Aplastic anemia; Classical PNH; FLAER; PNH; PNH-AA/MDS; PNH-sc

Year:  2020        PMID: 33867727      PMCID: PMC8012435          DOI: 10.1007/s12288-020-01302-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  15 in total

Review 1.  Implications of recent insights into the pathophysiology of paroxysmal nocturnal haemoglobinuria.

Authors:  P Hillmen; S J Richards
Journal:  Br J Haematol       Date:  2000-03       Impact factor: 6.998

2.  Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.

Authors:  Michael J Borowitz; Fiona E Craig; Joseph A Digiuseppe; Andrea J Illingworth; Wendell Rosse; D Robert Sutherland; Carl T Wittwer; Stephen J Richards
Journal:  Cytometry B Clin Cytom       Date:  2010-07       Impact factor: 3.058

Review 3.  Diagnosis and management of paroxysmal nocturnal hemoglobinuria.

Authors:  Charles Parker; Mitsuhiro Omine; Stephen Richards; Jun-Ichi Nishimura; Monica Bessler; Russell Ware; Peter Hillmen; Lucio Luzzatto; Neal Young; Taroh Kinoshita; Wendell Rosse; Gerard Socié
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

4.  A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America.

Authors:  Fan Yu; Yali Du; Bing Han
Journal:  Int J Hematol       Date:  2016-04-08       Impact factor: 2.490

5.  Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.

Authors:  Hubert Schrezenmeier; Petra Muus; Gérard Socié; Jeffrey Szer; Alvaro Urbano-Ispizua; Jaroslaw P Maciejewski; Robert A Brodsky; Monica Bessler; Yuzuru Kanakura; Wendell Rosse; Gus Khursigara; Camille Bedrosian; Peter Hillmen
Journal:  Haematologica       Date:  2014-01-31       Impact factor: 9.941

6.  Fluorescent Aerolysin (FLAER)-based paroxysmal nocturnal hemoglobinuria (PNH) screening: a single center experience from India.

Authors:  K Rahman; R Gupta; G Yadav; N Husein; M K Singh; S Nityanand
Journal:  Int J Lab Hematol       Date:  2017-04-22       Impact factor: 2.877

7.  Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays.

Authors:  Victor M Moyo; Galina L Mukhina; Elizabeth S Garrett; Robert A Brodsky
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

8.  Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.

Authors:  M Mahapatra; P K Singh; M Agarwal; M Prabhu; P Mishra; T Seth; S Tyagi; H P Patil; R Saxena
Journal:  J Assoc Physicians India       Date:  2015-03

9.  Clinical significance of a minor population of paroxysmal nocturnal hemoglobinuria-type cells in bone marrow failure syndrome.

Authors:  Hongbo Wang; Tatsuya Chuhjo; Shizuka Yasue; Mitsuhiro Omine; Shinji Nakao
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

10.  Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr.

Authors:  Cristina Muñoz-Linares; Emilio Ojeda; Rafael Forés; Miguel Pastrana; Martín Cabero; Daniel Morillo; Guiomar Bautista; Isolina Baños; Carmen Monteserín; Pilar Bravo; Esther Jaro; Teresa Cedena; Juan Luis Steegmann; Ana Villegas; José Rafael Cabrera
Journal:  Eur J Haematol       Date:  2014-05-13       Impact factor: 2.997

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.